Tech Company Financing Transactions
BioCopy Funding Round
Private investors joined a $8.7 million funding round for BioCopy. The financing round was announced by the company on 3/20/2025.
Transaction Overview
Company Name
Announced On
3/20/2025
Transaction Type
Venture Equity
Amount
$8,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will help initiate the establishment of BioCopy's automated ultra-high-throughput lab.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Lichtstrasse 35, Switzerland Innovation Park, Novartis Campu
Basel, CH-4056
Switzerland
Basel, CH-4056
Switzerland
Phone
Website
Email Address
Overview
We are revolutionizing drug discovery and development. With our unique AI-powered platform, next-generation cancer drug candidates can be developed into biotherapeutics with enhanced safety and superior efficacy - quickly and for all patients. Our platform is the new foundation for the pharmaceutical industry to produce next-generation biotherapeutics with a lasting and unprecedented therapeutic impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthias Wiedenfels
Browse more venture capital transactions:
Prev: 3/20/2025: Manifest Finance venture capital transaction
Next: 3/20/2025: SkySpecs venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs